Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial (2011)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1192/bjp.bp.110.080044
- Subjects: LÍTIO (TERAPIA;EFEITOS ADVERSOS); COGNIÇÃO (EFEITOS ADVERSOS)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The British journal of psychiatry
- ISSN: 0007-1250
- Volume/Número/Paginação/Ano: v. 198, n. 5, p. 351-356, 2011
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
FORLENZA, Orestes V. et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. The British journal of psychiatry, v. 198, n. 5, p. 351-356, 2011Tradução . . Disponível em: https://doi.org/10.1192/bjp.bp.110.080044. Acesso em: 26 abr. 2024. -
APA
Forlenza, O. V., Diniz, B. S., Radanovic, M., Santos, F. S., Talib, L. L., & Gattaz, W. F. (2011). Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. The British journal of psychiatry, 198( 5), 351-356. doi:10.1192/bjp.bp.110.080044 -
NLM
Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial [Internet]. The British journal of psychiatry. 2011 ; 198( 5): 351-356.[citado 2024 abr. 26 ] Available from: https://doi.org/10.1192/bjp.bp.110.080044 -
Vancouver
Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial [Internet]. The British journal of psychiatry. 2011 ; 198( 5): 351-356.[citado 2024 abr. 26 ] Available from: https://doi.org/10.1192/bjp.bp.110.080044 - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
Informações sobre o DOI: 10.1192/bjp.bp.110.080044 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
